| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.037 | 0.8 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.9 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.9 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.035 | 0.9 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.9 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |